Callan Capital’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-108,080
| Closed | -$309K | – | 370 |
|
|
2024
Q3 | $309K | Buy |
108,080
+24,000
| +29% | +$68.6K | 0.02% | 256 |
|
|
2024
Q2 | $246K | Buy |
84,080
+5,500
| +7% | +$16.1K | 0.02% | 261 |
|
|
2024
Q1 | $251K | Buy |
78,580
+2,021
| +3% | +$6.45K | 0.02% | 237 |
|
|
2023
Q4 | $257K | Hold |
76,559
| – | – | 0.02% | 188 |
|
|
2023
Q3 | $182K | Buy |
76,559
+4,000
| +6% | +$9.52K | 0.02% | 192 |
|
|
2023
Q2 | $128K | Buy |
72,559
+4,552
| +7% | +$8.01K | 0.01% | 176 |
|
|
2023
Q1 | $209K | Buy |
68,007
+5,660
| +9% | +$17.4K | 0.02% | 170 |
|
|
2022
Q4 | $330K | Buy |
+62,347
| New | +$330K | 0.04% | 133 |
|